{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:05:34Z","timestamp":1767863134306,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.anndiagpath.2022.152013","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T02:14:20Z","timestamp":1658456060000},"page":"152013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Diagnostic utility of the aberrant immunohistochemical expression of CD3 molecules for peripheral T-cell lymphomas"],"prefix":"10.1016","volume":"60","author":[{"given":"Tsugumi","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Kayano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Tsukasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2022.152013_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PPO.0000000000000452","article-title":"Diagnosis, risk stratification, and treatment of peripheral T-cell lymphomas: past and present","volume":"26","author":"Pearse","year":"2020","journal-title":"Cancer J"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pathol.2019.09.012","article-title":"Approach to nodal-based T-cell lymphomas","volume":"52","author":"de Leval","year":"2020","journal-title":"Pathology"},{"issue":"Suppl 1","key":"10.1016\/j.anndiagpath.2022.152013_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hon.2846","article-title":"What's new in peripheral T-cell lymphomas","volume":"39","author":"Luminari","year":"2021","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13045-020-01006-w","article-title":"Novel targeted therapies of T cell lymphomas","volume":"13","author":"I\u017cykowska","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cyto.10003","article-title":"An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry","volume":"50","author":"Gorczyca","year":"2002","journal-title":"Cytometry"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hon.2080","article-title":"Peripheral blood sCD3- CD4+ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma","volume":"32","author":"Singh","year":"2014","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0035","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.5858\/2006-130-1850-FCAOLC","article-title":"Flow cytometric analysis of lymphomas: current status and usefulness","volume":"130","author":"Kaleem","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0040","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Rev","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0045","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3324\/haematol.2009.021428","article-title":"Disturbed expression of the T-cell receptor\/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations","volume":"95","author":"Geissinger","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-immunol-042617-053429","article-title":"Cell biology of T cell receptor expression and regulation","volume":"36","author":"Alcover","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0055","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41586-019-1537-0","article-title":"Structural basis of assembly of the human T cell receptor-CD3 complex","volume":"573","author":"Dong","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0060","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.molimm.2003.11.017","article-title":"Molecular mechanisms for the assembly of the T cell receptor-CD3 complex","volume":"40","author":"Call","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0065","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1073\/pnas.87.18.7220","article-title":"Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex","volume":"87","author":"Blumberg","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-065X.2009.00835.x","article-title":"Hierarchical role of CD3 chains in thymocyte development","volume":"232","author":"Dave","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-09789-3_1","article-title":"T-cell receptor","volume":"640","author":"Rojo","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002485","article-title":"ITAM-mediated signaling by the T-cell antigen receptor","volume":"2","author":"Love","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-065X.2009.00843.x","article-title":"Organization of proximal signal initiation at the TCR:CD3 complex","volume":"232","author":"Guy","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nri2887","article-title":"Mechanisms for T cell receptor triggering","volume":"11","author":"van der Merwe","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0095","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cell.2008.09.044","article-title":"Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif","volume":"135","author":"Xu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.it.2003.08.003","article-title":"T-cell receptor signal transmission: who gives an ITAM?","volume":"24","author":"Pitcher","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molimm.2004.04.008","article-title":"B cell antigen receptor signaling 101","volume":"41","author":"Dal Porto","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0110","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.humpath.2013.10.023","article-title":"CD79B and MYD88 mutations in diffuse large B-cell lymphoma","volume":"45","author":"Kim","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2018.00665","article-title":"Putting on the brakes: regulatory kinases and phosphatases maintaining B cell anergy","volume":"9","author":"Franks","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/gcc.22126","article-title":"Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma","volume":"53","author":"Bohers","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ajh.26151","article-title":"2021 update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management","volume":"96","author":"Susanibar-Adaniya","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0135","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood.V87.2.839.bloodjournal872839","article-title":"Clarification of CD3 immunoreactivity in nasal T\/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+","volume":"87","author":"Chan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.semdp.2020.04.003","article-title":"T-cell and NK-cell lymphomas in the lung","volume":"37","author":"Pan","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0145","unstructured":"SH Swerdlow , International Agency for Research on C WHO classification of tumours of haematopoietic and lymphoid tissues."},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0150","series-title":"Extranodal NK-cell lymphoma","author":"Thida","year":"2021"},{"key":"10.1016\/j.anndiagpath.2022.152013_bb0155","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cll.2017.07.002","article-title":"Flow cytometry of T cells and T-cell neoplasms","volume":"37","author":"Craig","year":"2017","journal-title":"Clin Lab Med"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:35:55Z","timestamp":1761078955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913422001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":31,"alternative-id":["S1092913422001150"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152013","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic utility of the aberrant immunohistochemical expression of CD3 molecules for peripheral T-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152013"}}